FULGENT GENETICS, INC. Increase (Decrease) in Accounts Receivable
FULGENT GENETICS, INC. (FLGT) reported Increase (Decrease) in Accounts Receivable of -$17.16 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-07-30
- FULGENT GENETICS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$729.00K, a 108.83% decline year-over-year.
- FULGENT GENETICS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$16.43M, a 463.20% decline year-over-year.
- FULGENT GENETICS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $15.38M, a 15.40% increase year-over-year.
- FULGENT GENETICS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$4.91M, a 409.59% decline year-over-year.
- FULGENT GENETICS, INC. increase (decrease) in accounts receivable for fiscal 2025 was $23.25M, a 42.62% increase from fiscal 2024.
- FULGENT GENETICS, INC. increase (decrease) in accounts receivable for fiscal 2024 was $16.30M.
- FULGENT GENETICS, INC. increase (decrease) in accounts receivable for fiscal 2023 was -$2.39M.
- FULGENT GENETICS, INC. increase (decrease) in accounts receivable for fiscal 2022 was -$68.64M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$729.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$17.16M 10-Q · filed 2026-07-30 | -$1.78M derived: sum of 3 quarters · filed 2026-07-30 | -$6.69M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | -$16.43M 10-Q · filed 2026-05-01 | -$1.05M derived: sum of 2 quarters · filed 2026-05-01 | -$5.96M derived: sum of 3 quarters · filed 2026-05-01 | $2.30M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $15.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $10.47M derived: sum of 2 quarters · filed 2026-02-27 | $18.73M derived: sum of 3 quarters · filed 2026-07-30 | $23.25M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$4.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $3.35M derived: sum of 2 quarters · filed 2026-07-30 | $7.87M 10-Q · filed 2025-11-07 | $21.20M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $8.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $12.78M 10-Q · filed 2026-07-30 | $26.11M derived: sum of 3 quarters · filed 2026-07-30 | $27.69M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $4.52M 10-Q · filed 2026-05-01 | $17.85M derived: sum of 2 quarters · filed 2026-05-01 | $19.43M derived: sum of 3 quarters · filed 2026-05-01 | $22.31M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $13.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $14.91M derived: sum of 2 quarters · filed 2026-02-27 | $17.79M derived: sum of 3 quarters · filed 2026-02-27 | $16.30M 10-K · filed 2026-02-27 |
| 2024-09-30 | $1.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $4.46M derived: sum of 2 quarters · filed 2025-11-07 | $2.98M 10-Q · filed 2025-11-07 | $8.19M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $2.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $1.39M 10-Q · filed 2025-08-01 | $6.60M derived: sum of 3 quarters · filed 2026-02-27 | $18.66M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$1.48M 10-Q · filed 2025-05-02 | $3.72M derived: sum of 2 quarters · filed 2026-02-27 | $15.79M derived: sum of 3 quarters · filed 2026-02-27 | $5.46M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $5.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $17.27M derived: sum of 2 quarters · filed 2026-02-27 | $6.94M derived: sum of 3 quarters · filed 2026-02-27 | -$2.39M 10-K · filed 2026-02-27 |
| 2023-09-30 | $12.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $1.74M derived: sum of 2 quarters · filed 2024-11-08 | -$7.60M 10-Q · filed 2024-11-08 | -$52.02M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | -$10.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | -$19.66M 10-Q · filed 2024-08-02 | -$64.08M derived: sum of 3 quarters · filed 2025-02-28 | -$86.49M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | -$9.33M 10-Q · filed 2024-05-03 | -$53.76M derived: sum of 2 quarters · filed 2025-02-28 | -$76.17M derived: sum of 3 quarters · filed 2025-02-28 | -$110.89M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | -$44.42M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$66.84M derived: sum of 2 quarters · filed 2025-02-28 | -$101.56M derived: sum of 3 quarters · filed 2025-02-28 | -$68.64M 10-K · filed 2025-02-28 |
| 2022-09-30 | -$22.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$57.14M derived: sum of 2 quarters · filed 2023-11-03 | -$24.21M 10-Q · filed 2023-11-03 | -$1.51M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$34.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$1.80M 10-Q · filed 2023-08-04 | $20.90M derived: sum of 3 quarters · filed 2024-02-28 | -$11.64M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $32.92M 10-Q · filed 2023-05-05 | $55.63M derived: sum of 2 quarters · filed 2024-02-28 | $23.08M derived: sum of 3 quarters · filed 2024-02-28 | -$43.97M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $22.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$9.84M derived: sum of 2 quarters · filed 2024-02-28 | -$76.89M derived: sum of 3 quarters · filed 2024-02-28 | -$42.30M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$32.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$99.60M derived: sum of 2 quarters · filed 2022-11-07 | -$65.00M 10-Q · filed 2022-11-07 | $28.92M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$67.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$32.46M 10-Q · filed 2022-08-04 | $61.46M derived: sum of 3 quarters · filed 2023-02-28 | $138.58M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $34.59M 10-Q · filed 2022-05-05 | $128.52M derived: sum of 2 quarters · filed 2023-02-28 | $205.64M derived: sum of 3 quarters · filed 2023-02-28 | $213.18M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $93.92M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $171.04M derived: sum of 2 quarters · filed 2023-02-28 | $178.58M derived: sum of 3 quarters · filed 2023-02-28 | $178.48M 10-K · filed 2023-02-28 |
| 2020-09-30 | $77.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $84.66M derived: sum of 2 quarters · filed 2021-11-09 | $84.56M 10-Q · filed 2021-11-09 | $85.98M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $7.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $7.44M 10-Q · filed 2021-08-10 | $8.86M derived: sum of 3 quarters · filed 2022-02-28 | $8.64M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | -$104.00K 10-Q · filed 2021-05-07 | $1.32M derived: sum of 2 quarters · filed 2022-02-28 | $1.10M derived: sum of 3 quarters · filed 2022-02-28 | $2.15M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $1.21M derived: sum of 2 quarters · filed 2022-02-28 | $2.25M derived: sum of 3 quarters · filed 2022-02-28 | $839.00K 10-K · filed 2022-02-28 |
| 2019-09-30 | -$220.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $826.00K derived: sum of 2 quarters · filed 2020-11-09 | -$588.00K 10-Q · filed 2020-11-09 | -$611.00K derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$368.00K 10-Q · filed 2020-08-05 | -$391.00K derived: sum of 3 quarters · filed 2020-08-05 | $612.00K derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | -$1.41M 10-Q · filed 2020-05-06 | -$1.44M derived: sum of 2 quarters · filed 2020-05-06 | -$434.00K derived: sum of 3 quarters · filed 2020-05-06 | -$157.00K derived: sum of 4 quarters · filed 2020-05-06 |
| 2018-12-31 | -$23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $980.00K derived: sum of 2 quarters · filed 2020-03-13 | $1.26M derived: sum of 3 quarters · filed 2020-03-13 | $1.97M 10-K · filed 2020-03-13 |
| 2018-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $1.28M derived: sum of 2 quarters · filed 2019-11-08 | $1.99M 10-Q · filed 2019-11-08 | $2.54M derived: sum of 4 quarters · filed 2019-11-08 |
| 2018-06-30 | $277.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $990.00K 10-Q · filed 2019-08-12 | $1.53M derived: sum of 3 quarters · filed 2019-08-12 | $954.00K derived: sum of 4 quarters · filed 2019-08-12 |
| 2018-03-31 | $713.00K 10-Q · filed 2019-05-10 | $1.26M derived: sum of 2 quarters · filed 2019-05-10 | $677.00K derived: sum of 3 quarters · filed 2019-05-10 | $262.00K derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | $545.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | -$36.00K derived: sum of 2 quarters · filed 2019-03-22 | -$451.00K derived: sum of 3 quarters · filed 2019-03-22 | -$214.00K 10-K · filed 2019-03-22 |
| 2017-09-30 | -$581.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$996.00K derived: sum of 2 quarters · filed 2018-11-09 | -$759.00K 10-Q · filed 2018-11-09 | -$698.00K derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-06-30 | -$415.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | -$178.00K 10-Q · filed 2018-08-13 | -$117.00K derived: sum of 3 quarters · filed 2018-08-13 | $1.50M derived: sum of 4 quarters · filed 2018-08-13 |
| 2017-03-31 | $237.00K 10-Q · filed 2018-05-14 | $298.00K derived: sum of 2 quarters · filed 2018-05-14 | $1.91M derived: sum of 3 quarters · filed 2018-05-14 | $1.88M derived: sum of 4 quarters · filed 2018-05-14 |
| 2016-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $1.67M derived: sum of 2 quarters · filed 2018-03-20 | $1.65M derived: sum of 3 quarters · filed 2018-03-20 | $2.32M 10-K · filed 2018-03-20 |
| 2016-09-30 | $1.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $1.58M derived: sum of 2 quarters · filed 2017-11-13 | $2.26M 10-Q · filed 2017-11-13 | $2.76M derived: sum of 4 quarters · filed 2017-11-13 |
| 2016-06-30 | -$27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $649.00K 10-Q · filed 2017-08-14 | $1.15M derived: sum of 3 quarters · filed 2017-08-14 | |
| 2016-03-31 | $676.00K 10-Q · filed 2017-05-09 | $1.18M derived: sum of 2 quarters · filed 2017-05-09 | ||
| 2015-12-31 | $503.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | $1.78M 10-K · filed 2017-03-17 | ||
| 2015-09-30 | $1.28M 10-Q · filed 2016-11-14 | |||
| 2014-12-31 | $416.00K 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |